MANAMIX
Dead / Abandoned — Abandoned — after ex parte appeal (as of 18 Oct 2022)
What this means for you
This application is over — abandoned 18 Oct 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88246875
- Mark type
- Stylized text
- Filed
- 02 Jan 2019
- Published for opposition
- 22 Oct 2019
- Abandoned
- 18 Oct 2022
- Attorney of record
- KRISTEN S. RUISI
Goods and services
- Class 001 — Chemicals: Synthetic tumor antigen peptide mixes for use in the manufacture of pharmaceutical preparations for activating t-cells for use in adoptive t-cell therapy for the treatment of hematological and solid cancers
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, Synthetic tumor antigen peptide mixes for use in activating t-cells for use in adoptive t-cell therapy for the treatment of hematological and solid cancers
Owner
- Mana Therapeutics, Inc., Bethesda, MD, US
- Mana Therapeutics, Inc., Bethesda, MD, US
Prosecution history
- 21 Oct 2022 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 21 Oct 2022 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 18 Oct 2022 — ABANDONMENT - AFTER EX PARTE APPEAL
- 18 Oct 2022 — EXPARTE APPEAL TERMINATED
- 06 Sept 2022 — EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
- 24 Jun 2022 — NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
- 24 Jun 2022 — ACTION DENYING REQ FOR RECON E-MAILED
- 24 Jun 2022 — SU - ACTION CONTINUING FINAL - WRITTEN
- 16 Jun 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Jun 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Jun 2022 — ASSIGNED TO LIE
- 14 Jun 2022 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 14 Jun 2022 — EX PARTE APPEAL-INSTITUTED
- 14 Jun 2022 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 14 Jun 2022 — EXPARTE APPEAL RECEIVED AT TTAB